7 reports

  • OTHER PROMINENT VENDORS
  • Strength

Later in July 2013, Cubist Pharmaceuticals acquired Trius Therapeutics.

  • Anti-Infective
  • Pharmaceutical
  • Allergan plc
  • Bayer AG
  • Nektar Therapeutics
  • OA - PROMISING DRUGS IN CLINICAL DEVELOPMENT, 2015
  • PRODUCT PROFILE - NKTR-181

TAKEDA PHARMACEUTICAL COMPANY LIMITED (2016).

  • Epidemiology
  • Pharmaceutical
  • Therapy
  • Forecast
  • Nektar Therapeutics
  • APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
  • POLYMER DRUG CONJUGATES: PROFILED DRUGS

SUN PHARMA ##.

  • Clinical Trial
  • Nanobiotechnology
  • Pharmaceutical
  • Therapy
  • Nektar Therapeutics
  • 8. Competitive Landscape
  • 1. Executive summary

Egalet Corporation is a specialty pharmaceutical company that is engaged in developing planning to commercialize proprietary, abuse-deterrent pharmaceutical products for the treatment of pain and other indications.

  • Opioid
  • Pharmaceutical
  • United States
  • Forecast
  • Nektar Therapeutics
  • Nektar Therapeutics, Pharmaceuticals & Healthcare, Deal Details
  • Nektar Therapeutics Enters into Agreement with Takeda Pharma
  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • Nektar Therapeutics
  • Nektar Therapeutics, Key Facts
  • Nektar Therapeutics - Research and Development Overview

Global Markets Direct aims to cover major news events and deals in the pharmaceutical industry, updated on daily basis.

  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • Nektar Therapeutics
  • PARTNERSHIP - DEAL REPORTS

West Pharmaceuticals Services, Inc.

  • Pharmaceutical
  • United Kingdom
  • United States
  • Corporate Finance
  • Nektar Therapeutics